FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "OSRX, Inc.(117108300)" | 83826-9065 | 83826-9065-0 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9057 | 83826-9057-2 | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9055 | 83826-9055-5 | Prednisolone Sodium Phosphate; Bromfenac Sodium | 10 mg/1 mL; .75 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9033 | 83826-9033-5 | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9018 | 83826-9018-5 | Bimatoprost; Timolol Maleate | .1 mg/1 mL; 5 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9032 | 83826-9032-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride | .1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9003 | 83826-9003-5 | Bimatoprost; Timolol Maleate; Dorzolamide Hydrochloride; Brimonidine Tartrate | .1 mg/1 mL; 5 mg/1 mL; 20 mg/1 mL; 1 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9006 | 83826-9006-5 | Timolol Maleate; Brimonidine Tartrate; Dorzolamide Hydrochloride | 5 mg/1 mL; 1 mg/1 mL; 20 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9066 | 83826-9066-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9059 | 83826-9059-2 | Dorzolamide Hydrochloride; Brimonidine Tartrate | 20 mg/1 mL; 1 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9030 | 83826-9030-5 | Dorzolamide Hydrochloride; Brimonidine Tartrate; Bimatoprost | 20 mg/1 mL; 1 mg/1 mL; .1 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9010 | 83826-9010-3 | Atropine Sulfate | .1 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9011 | 83826-9011-3 | Atropine Sulfate | .25 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9012 | 83826-9012-3 | Atropine Sulfate | .5 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9034 | 83826-9034-5 | Moxifloxacin Hydrochloride; Bromfenac Sodium | 10 mg/1 mL; 75 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9004 | 83826-9004-1 | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9017 | 83826-9017-8 | Moxifloxacin Hydrochloride; Ketorolac Tromethamine; Prednisolone Sodium Phosphate | 5 mg/1 mL; 5 mg/1 mL; 10 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9014 | 83826-9014-5 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "OSRX, Inc.(117108300)" | 83826-9016 | 83826-9016-8 | Moxifloxacin Hydrochloride; Prednisolone Sodium Phosphate; Bromfenac Sodium | 5 mg/1 mL; 10 mg/1 mL; .75 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-978 | 69194-978-10 | Phenylephrine Hydrochloride | 20 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-980 | 69194-980-10 | Phenylephrine Hydrochloride | 40 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-979 | 69194-979-10 | Phenylephrine Hydrochloride | 25 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-974 | 69194-974-10 | Phenylephrine Hydrochloride | 50 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-608 | 69194-608-01 | Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL; 10 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-687 | 69194-687-01 | Povidone-Iodine | 5 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-745 | 69194-745-01 | Povidone-Iodine | 5 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-131 | 69194-131-01 | Bevacizumab | 1.25 mg/.05 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-138 | 69194-138-01 | Bupivacaine Hydrochloride; Lidocaine Hydrochloride | 3.75 mg/1 mL; 20 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-625 | 69194-625-01 | Calcium Chloride | 20 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | Calcium Gluconate | 25 mg/1 g | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-392 | 69194-392-01 | Calcium Gluconate | 10 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-134 | 69194-134-01 | Calcium Gluconate | 25 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-452 | 69194-452-01 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-762 | 69194-762-01 | Tropicamide; Phenylephrine Hydrochloride | 10 mg/1 mL; 25 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | Vancomycin Hydrochloride | 1 mg/.1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-972 | 69194-972-10 | Vasopressin | 20 [USP'U]/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-973 | 69194-973-10 | Vasopressin | 40 [USP'U]/100 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | Cholic Acid | 4 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | Dexamethasone Sodium Phosphate | 24 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 6-6-Dideuteroglucose | 72.9 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-104 | 69194-104-10 | Diltiazem Hydrochloride | 125 mg/125 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-112 | 69194-112-01 | Edetate Disodium | 15 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-976 | 69194-976-10 | Epinephrine | 4 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-975 | 69194-975-10 | Epinephrine | 8 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-977 | 69194-977-10 | Epinephrine | 5 mg/250 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | Epinephrine; Lidocaine Hydrochloride | .25 mg/1 mL; 7.5 mg/1 mL | 2025-1 | source_no_ndc | 2026-10-17 | ||||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-886 | 69194-886-01 | Fentanyl Citrate | 10 ug/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-135 | 69194-135-01 | Foscarnet Sodium | 2.4 mg/.1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-887 | 69194-887-01 | Ketamine Hydrochloride | 2.5 mg/1 mL | 2025-1 | valid | 2026-10-17 | ||
| "Pine Pharmaceuticals, LLC(079432784)" | 69194-740 | 69194-740-01 | Lidocaine Hydrochloride | 40 mg/1 mL | 2025-1 | valid | 2026-10-17 |